Modeling intra-individual inter-trial EEG response variability in autism.
Mingfei DongDonatello TelescaMichele GuindaniCatherine SugarSara J WebbShafali JesteAbigail DickinsonApril R LevinFrederick ShicAdam NaplesSusan FajaGeraldine DawsonJames C McPartlandDamla ŞentürkPublished in: Statistics in medicine (2024)
Autism spectrum disorder (autism) is a prevalent neurodevelopmental condition characterized by early emerging impairments in social behavior and communication. EEG represents a powerful and non-invasive tool for examining functional brain differences in autism. Recent EEG evidence suggests that greater intra-individual trial-to-trial variability across EEG responses in stimulus-related tasks may characterize brain differences in autism. Traditional analysis of EEG data largely focuses on mean trends of the trial-averaged data, where trial-level analysis is rarely performed due to low neural signal to noise ratio. We propose to use nonlinear (shape-invariant) mixed effects (NLME) models to study intra-individual inter-trial EEG response variability using trial-level EEG data. By providing more precise metrics of response variability, this approach could enrich our understanding of neural disparities in autism and potentially aid the identification of objective markers. The proposed multilevel NLME models quantify variability in the signal's interpretable and widely recognized features (e.g., latency and amplitude) while also regularizing estimation based on noisy trial-level data. Even though NLME models have been studied for more than three decades, existing methods cannot scale up to large data sets. We propose computationally feasible estimation and inference methods via the use of a novel minorization-maximization (MM) algorithm. Extensive simulations are conducted to show the efficacy of the proposed procedures. Applications to data from a large national consortium find that children with autism have larger intra-individual inter-trial variability in P1 latency in a visual evoked potential (VEP) task, compared to their neurotypical peers.
Keyphrases
- autism spectrum disorder
- resting state
- study protocol
- phase iii
- phase ii
- functional connectivity
- clinical trial
- intellectual disability
- working memory
- electronic health record
- big data
- randomized controlled trial
- healthcare
- open label
- machine learning
- young adults
- mental health
- white matter
- blood brain barrier
- risk assessment
- single cell
- high density
- placebo controlled